News

Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal
Mayne Pharma shares posted their worst day in 16 years on Wednesday after U.S.-based Cosette Pharmaceuticals initiated a ...
Fierce Pharma10d
Mayne hit by 'misleading' drug safety claims from the FDA ahead of $430M buyout
Mayne Pharma is in trouble with the FDA. The agency accused Mayne of giving a misleading impression of the risks of its oral ...
HotCopper on MSN2d
Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up
Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets this week, with company value as much as -33% lower — ...
Capital Brief on MSN1d
Mayne Pharma shares partly recover after difficult week
Mayne Pharma shares were rallying on Friday, partly reversing deep losses this week amid a tussle with the ASX and a threat ...
Yahoo Finance3mon
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction.
The Australian Financial Review2y
Infomedia wrangler Viburnum butts heads with Mayne Pharma’s board
Bombed-out listed drugmaker Mayne Pharma is in the firing line of activist investor Viburnum Funds, which is taking the board to task after the drug manufacturer sliced its $113 million capital ...